Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News (Page 3)
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
American Lung Association Releases Annual 'State of Lung Cancer' Report
MONDAY, Dec. 2, 2024 – The lung cancer survival rate improved 26 percent in the last five years, according to the "State of Lung Cancer" report published by the American Lung Association. The annual...
Smoker or Former Smoker? Here Are 4 Key Things You Need to Know
MONDAY, Dec.2, 2024 — Doctors have potent new weapons against the deadliest cancer in America and they want to make sure they're on the radar of current and former smokers. "Lung cancer screening is t...
Diabetes Drug Metformin Might Help Fight Lung Cancer
WEDNESDAY, Nov. 27, 2024 – Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows. Metformin...
There's Been a Big Improvement in Lung Cancer Survival
TUESDAY, Nov. 19, 2024 – More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows. "There is more work to do, but I am incredibly...
Few High-Risk Individuals Have Heard of, Discuss Lung Cancer Screening
TUESDAY, Nov. 12, 2024 – Few high-risk individuals have heard of or have discussed lung cancer screening (LCS) with a health care practitioner, according to a research letter published online Oct....
Early Steps to a Breath Test for Lung Cancer
THURSDAY, Nov. 7, 2024 – An experimental portable device might be able to detect lung cancer from a person’s exhaled breath, researchers report. The device contains “nanoflake” sensors that can detec...
Tobacco-Free Generation Could Prevent 40 Percent of Predicted Lung Cancer Deaths Globally
MONDAY, Oct. 7, 2024 – Implementation of a tobacco-free generation could substantially reduce global lung cancer mortality, according to a study published in the October issue of The Lancet Public ...
U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J.--(BUSINESS WIRE) Oct 03, 2024 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo ® (nivolumab) for the treatment of ...
Rybrevant (amivantamab-vmjw) Plus Standard of Care Approved in the U.S. as First and Only Targeted Regimen to Cut Risk of Disease Progression by More Than Half in Second-Line EGFR-Mutated Advanced Lung Cancer
RARITAN, New Jersey (September 19, 2024) – Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) in combination with s...
FDA Approves Rybrevant (amivantamab-vmjw) Plus Lazcluze (lazertinib) for Patients with EGFR-Mutated Advanced Lung cancer
RARITAN, N.J., Aug. 20, 2024 /PRNewswire/ – Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved Rybrevant® (amivantamab-vmjw) plus Lazcluze™ (l...
Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
MONDAY, Sept. 30, 2024 – The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according to a study published online Sept. 24 in the...
Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery
WEDNESDAY, Sept. 25, 2024 – A postoperative wearable device may improve physical activity and patient-reported dyspnea at six months after lung cancer surgery, according to a study published online...
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
THURSDAY, Sept. 19, 2024 – For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to...
Early, Virtual Palliative Care Feasible for Advanced Lung Cancer
TUESDAY, Sept. 17, 2024 – The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with advanced non-small cell lung cancer (NSCLC),...
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
FRIDAY, Sept. 13, 2024 – Tusamitamab ravtansine (tusa rav), an immunoconjugate, does not improve progression-free survival (PFS) in patients with previously treated advanced nonsquamous non-small...